These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1887527)

  • 1. Crystalluria in marathon runners. III. Stone-forming subjects.
    Rodgers AL; Greyling KG; Noakes TD
    Urol Res; 1991; 19(3):189-92. PubMed ID: 1887527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystalluria in marathon runners. 1. Standard marathon--males.
    Irving RA; Noakes TD; Rodgers AL; Swartz L
    Urol Res; 1986; 14(6):289-94. PubMed ID: 3811077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystalluria in marathon runners. IV. Black subjects.
    Rodgers AL; Cox TA; Noakes TD; Lombard CJ
    Urol Res; 1992; 20(1):27-33. PubMed ID: 1736484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of calcium oxalate crystalluria on renal and vesical urines in stone formers and normal subjects.
    Robert M; Boularan AM; Delbos O; Guiter J; Descomps B
    Urol Int; 1998; 60(1):41-6. PubMed ID: 9519420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystalluria in marathon runners. II. Ultra-marathon--males and females.
    Rodgers AL; Greyling KG; Irving RA; Noakes TD
    Urol Res; 1988; 16(2):89-93. PubMed ID: 3369003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the risk of stone formation: study on crystalluria in patients with recurrent calcium oxalate urolithiasis.
    Robert M; Boularan AM; Delbos O; Monnier L; Grasset D
    Eur Urol; 1996; 29(4):456-61. PubMed ID: 8791054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serial crystalluria determination and the risk of recurrence in calcium stone formers.
    Daudon M; Hennequin C; Boujelben G; Lacour B; Jungers P
    Kidney Int; 2005 May; 67(5):1934-43. PubMed ID: 15840041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Observations on in vitro and in vivo calcium oxalate crystalluria in primary calcium stone formers and normal subjects.
    Azoury R; Robertson WG; Garside J
    Br J Urol; 1987 Mar; 59(3):211-3. PubMed ID: 3567480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulatory effect of the 23-kD calcium oxalate monohydrate binding protein on calcium oxalate stone formation during oxalate stress.
    Asokan D; Kalaiselvi P; Varalakshmi P
    Nephron Physiol; 2004; 97(1):p23-30. PubMed ID: 15153748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new urinary test for stone "activity".
    Hallson PC; Rose GA
    Br J Urol; 1978 Dec; 50(7):442-8. PubMed ID: 753493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of vitamin C supplements on urinary oxalate and pH in calcium stone-forming patients.
    Baxmann AC; De O G Mendonça C; Heilberg IP
    Kidney Int; 2003 Mar; 63(3):1066-71. PubMed ID: 12631089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystallization properties in urine from calcium oxalate stone formers.
    Tiselius HG; Bek-Jensen H; Fornander AM; Nilsson MA
    J Urol; 1995 Sep; 154(3):940-6. PubMed ID: 7637098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of stone-forming risk by measuring crystal formation in whole urine with gel model.
    Roehrborn CG; Schneider HJ; Rugendorff EW
    Urology; 1986 Jun; 27(6):531-6. PubMed ID: 3716052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of urine dilution on quantity, size and aggregation of calcium oxalate crystals induced in vitro by an oxalate load.
    Guerra A; Allegri F; Meschi T; Adorni G; Prati B; Nouvenne A; Novarini A; Maggiore U; Fiaccadori E; Borghi L
    Clin Chem Lab Med; 2005; 43(6):585-9. PubMed ID: 16006253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium oxalate monohydrate binding protein: a diagnostic biomarker for calcium oxalate kidney stone formers.
    Asokan D; Kalaiselvi P; Muhammed Farooq S; Varalakshmi P
    Urol Res; 2004 Oct; 32(5):357-61. PubMed ID: 15365653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi].
    Hess B
    Ther Umsch; 2003 Feb; 60(2):79-87. PubMed ID: 12649986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical value of crystalluria and quantitative morphoconstitutional analysis of urinary calculi.
    Frochot V; Daudon M
    Int J Surg; 2016 Dec; 36(Pt D):624-632. PubMed ID: 27847293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory activity of whole urine: a comparison of urines from stone formers and healthy subjects.
    Ryall RL; Hibberd CM; Mazzachi BC; Marshall VR
    Clin Chim Acta; 1986 Jan; 154(1):59-67. PubMed ID: 3943225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation by macromolecules of calcium oxalate crystal aggregation in stone formers.
    Wesson JA; Ganne V; Beshensky AM; Kleinman JG
    Urol Res; 2005 Jun; 33(3):206-12. PubMed ID: 15864572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.